Suchergebnisse - "Falkson, Carla I"

PubPharm (62)

1

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials : A Secondary Analysis of NRG Oncology Randomized Clinical Trials

enthalten in: JAMA network open | 2023

von Hallemeier, C. | Moughan, J. | Haddock, M. | +23

2

Inflammatory breast cancer with excellent response to pembrolizumab-chemotherapy combination : A case report

enthalten in: Breast disease | 2022

von Kharel, Z. | Nemer, O. | Xi, W. | +4

ErratumIn: Breast Dis. 2022;41(1):363. - PMID 36057835

3

Erratum to : Inflammatory breast cancer with excellent response to pembrolizumab-chemotherapy combination: A case report

enthalten in: Breast disease | 2022

von Kharel, Z. | Nemer, O. | Xi, W. | +4

ErratumFor: Breast Dis. 2022;41(1):255-260. - PMID 35599460

4

Adjuvant tamoxifen adherence in male patients with breast cancer : An ongoing challenge

enthalten in: Cancer | 2022

von Falkson, C.

CommentOn: Cancer. 2022 Jan 1;128(1):59-64. - PMID 34597415

5

Adjuvant tamoxifen adherence in male patients with breast cancer : An ongoing challenge

enthalten in: Cancer | 2022

von Falkson, C.

6

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

enthalten in: NPJ breast cancer | 2021

von Yee, D. | Isaacs, C. | Wolf, D. | +52

7

Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2021

von Kizub, D. | Miao, J. | Schubert, M. | +8

8

An Open Label, Pilot Study of Veliparib and Lapatinib in Patients with Metastatic, Triple Negative Breast Cancer

enthalten in: ResearchSquare.com | 2021

von Stringer-Reasor, E. | May, J. | Olariu, E. | +10

9

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer

enthalten in: Breast cancer research : BCR | 2021

von Stringer-Reasor, E. | May, J. | Olariu, E. | +11

10

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer

enthalten in: Breast cancer research | 2021

von Stringer-Reasor, E. | May, J. | Olariu, E. | +11

1
2
3
4
5
6
7
Nächster »
[7]